{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/d9/federal/","compound":{"slug":"d9","name":"Delta-9 THC (hemp-derived)"},"federal":[{"form":"vape","status":"restricted","headline":"Hemp delta-9 THC vape - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"capsule","status":"restricted","headline":"Hemp delta-9 THC capsule - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)","url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","pinpoint":null,"primary":true},{"title":"FDA Warning Letter, STNR Creations, LLC (MARCS-CMS 698700), July 16, 2025","url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stnr-creations-llc-698700-07162025","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"drink","status":"restricted","headline":"Hemp delta-9 THC beverage - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)","url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","pinpoint":null,"primary":true},{"title":"FDA Warning Letter, STNR Creations, LLC (MARCS-CMS 698700), July 16, 2025","url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stnr-creations-llc-698700-07162025","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"edible","status":"restricted","headline":"Hemp delta-9 THC edible - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)","url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","pinpoint":null,"primary":true},{"title":"FDA Warning Letter, STNR Creations, LLC (MARCS-CMS 698700), July 16, 2025","url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stnr-creations-llc-698700-07162025","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"flower","status":"restricted","headline":"Hemp delta-9 THC flower - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"other","status":"restricted","headline":"Hemp delta-9 THC other - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"powder","status":"restricted","headline":"Hemp delta-9 THC powder - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)","url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","pinpoint":null,"primary":true},{"title":"FDA Warning Letter, STNR Creations, LLC (MARCS-CMS 698700), July 16, 2025","url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stnr-creations-llc-698700-07162025","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"raw_material","status":"restricted","headline":"Hemp delta-9 THC raw material - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"tincture","status":"restricted","headline":"Hemp delta-9 THC tincture - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)","url":"https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd","pinpoint":null,"primary":true},{"title":"FDA Warning Letter, STNR Creations, LLC (MARCS-CMS 698700), July 16, 2025","url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/stnr-creations-llc-698700-07162025","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]},{"form":"topical","status":"restricted","headline":"Hemp delta-9 THC topical - federally unscheduled inside the hemp definition; 0.4 mg per container cap lands Nov 12 2026","tier":"concentration_cap","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]}]}